Senior insider sale
President and CEO at TAYSHA GENE THERAPIES, INC. — senior position signals high conviction
$699.6K
1.01M shares
What this filing means
SESSION R.A. II plans to sell 1.01M shares of TAYSHA GENE THERAPIES, INC. valued at approximately $699.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/20/2023ACC: 0001968582-23-000263
DirectorOfficer10% Owner· President and CEO
Since Sep 2020
1.01M
Shares to sell
$699.6K
Approx. market value
1.01M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Founder Shares
N/A
9/23/2020
1.01MTotal acquired1.01M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/23/2020 | Founder Shares N/A | 1.01M | — |
| Total | 1.01M | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
1.01M
Market value
$699.6K
6/20/2023
Total
Units
1.01M
Value
$699.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/20/2023 | 1.01M | $699.6K | Nasdaq | Planned |
| Total | 1.01M | $699.6K | ||